Article Information
History
- January 14, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Ruturaj R. Masvekar1,
- Peter Kosa1,
- Kimberly Jin1,
- Kerry Dobbs1,
- Michael A. Stack1,
- Riccardo Castagnoli1,
- Virginia Quaresima2,
- Helen C. Su1,
- Luisa Imberti2,
- Luigi D. Notarangelo1 and
- Bibiana Bielekova1,*
- 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
- 2CREA Laboratory (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
- ↵*To whom correspondence should be addressed: Bibiana Bielekova, MD, Neuroimmunological Diseases Section (NDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Building 10, Room 5N248, 10 Center Drive, MSC1444, Bethesda, Maryland 20892, USA. (Bibi.Bielekova{at}nih.gov).
Posted January 14, 2022.
Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality
